Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China · Delayed Price · Currency is CNY 48.29
-3.75 (-7.21%)
At close: May 12, 2026
Shanghai OPM Biosciences Market Cap
Shanghai OPM Biosciences has a market cap or net worth of 7.25 billion as of May 12, 2026. Its market cap has increased by 81.75% in one year.
Market Cap
7.25B
Enterprise Value
5.61B
Revenue
453.39M
Ranking
n/a
PE Ratio
176.40
Stock Price
48.29
Market Cap Chart
Since September 2, 2022, Shanghai OPM Biosciences's market cap has decreased from 10.43B to 7.25B, a decrease of -30.52%. That is a compound annual growth rate of -9.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 7.25B | 29.95% |
| Dec 31, 2025 | 5.58B | 34.44% |
| Dec 31, 2024 | 4.15B | -34.49% |
| Dec 29, 2023 | 6.33B | -25.16% |
| Dec 30, 2022 | 8.46B | -18.89% |
| Sep 2, 2022 | 10.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Kanghua Biological Products | 8.05B |
| Acrobiosystems | 7.73B |
| Jiangsu Aidea Pharmaceutical Group | 7.24B |
| Suzhou Fengbei Biotech Stock | 7.20B |
| Innovita Biological Technology | 7.12B |
| Xiangxue Pharmaceutical | 7.04B |
| Wuhan Keqian Biology Co.,Ltd | 6.97B |
| Anhui Huaheng Biotechnology | 6.95B |